<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Henrey A</submitter><funding>CIHR</funding><pubmed_abstract>BACKGROUND:Validated clinical prediction models to identify children with poor prognosis at the time of juvenile idiopathic arthritis (JIA) diagnosis would be very helpful for tailoring treatments, and avoiding under- or over-treatment. Our objective was to externally validate Nordic clinical prediction models in Canadian patients with JIA. METHODS:We used data from 513 subjects at the 3-year follow-up from the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort. The predicted outcomes were non-achievement of remission, severe disease course, and functional disability. The Nordic models were evaluated exactly as published and after fine-tuning the logistic regression coefficients using multiple data splits of the Canadian cohort. Missing data was handled wit</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pagination>10</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6964007</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.</pubmed_title><pmcid>PMC6964007</pmcid><pubmed_authors>Yeung RSM</pubmed_authors><pubmed_authors>Haddad E</pubmed_authors><pubmed_authors>Silverman E</pubmed_authors><pubmed_authors>Lang B</pubmed_authors><pubmed_authors>Shiff NJ</pubmed_authors><pubmed_authors>Dancey P</pubmed_authors><pubmed_authors>Rosenberg AM</pubmed_authors><pubmed_authors>Spiegel L</pubmed_authors><pubmed_authors>Benseler SM</pubmed_authors><pubmed_authors>Dorval J</pubmed_authors><pubmed_authors>Jurencak R</pubmed_authors><pubmed_authors>Henrey A</pubmed_authors><pubmed_authors>Bruns A</pubmed_authors><pubmed_authors>Chan M</pubmed_authors><pubmed_authors>Feldman BM</pubmed_authors><pubmed_authors>Rumsey DG</pubmed_authors><pubmed_authors>Barsalou J</pubmed_authors><pubmed_authors>Morishita K</pubmed_authors><pubmed_authors>Petty RE</pubmed_authors><pubmed_authors>Larche M</pubmed_authors><pubmed_authors>Watanabe Duffy K</pubmed_authors><pubmed_authors>Berard RA</pubmed_authors><pubmed_authors>St Cyr C</pubmed_authors><pubmed_authors>Gibbon M</pubmed_authors><pubmed_authors>Chedeville G</pubmed_authors><pubmed_authors>Bolaria R</pubmed_authors><pubmed_authors>Turvey SE</pubmed_authors><pubmed_authors>Gerhold K</pubmed_authors><pubmed_authors>Roth J</pubmed_authors><pubmed_authors>Nordal E</pubmed_authors><pubmed_authors>Johnson N</pubmed_authors><pubmed_authors>Huber AM</pubmed_authors><pubmed_authors>Feldman D</pubmed_authors><pubmed_authors>ReACCh-Out and NoSPeR Investigators</pubmed_authors><pubmed_authors>Cameron B</pubmed_authors><pubmed_authors>Tse SM</pubmed_authors><pubmed_authors>Duffy CM</pubmed_authors><pubmed_authors>LeBlanc C</pubmed_authors><pubmed_authors>Guzman J</pubmed_authors><pubmed_authors>Stringer E</pubmed_authors><pubmed_authors>Scuccimarri R</pubmed_authors><pubmed_authors>Tucker LB</pubmed_authors><pubmed_authors>Houghton K</pubmed_authors><pubmed_authors>Ramsey SE</pubmed_authors><pubmed_authors>Levy DM</pubmed_authors><pubmed_authors>Schneider R</pubmed_authors><pubmed_authors>Campillo S</pubmed_authors><pubmed_authors>Cabral DA</pubmed_authors><pubmed_authors>Oen K</pubmed_authors><pubmed_authors>Chetaille AL</pubmed_authors><pubmed_authors>Rypdal M</pubmed_authors><pubmed_authors>Miettunen P</pubmed_authors><pubmed_authors>Boire G</pubmed_authors><pubmed_authors>Laxer RM</pubmed_authors><pubmed_authors>Loughin T</pubmed_authors><pubmed_authors>Ellsworth J</pubmed_authors><pubmed_authors>Gross K</pubmed_authors><pubmed_authors>Luca N</pubmed_authors><pubmed_authors>Schmeling H</pubmed_authors><pubmed_authors>Rypdal V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.</name><description>BACKGROUND:Validated clinical prediction models to identify children with poor prognosis at the time of juvenile idiopathic arthritis (JIA) diagnosis would be very helpful for tailoring treatments, and avoiding under- or over-treatment. Our objective was to externally validate Nordic clinical prediction models in Canadian patients with JIA. METHODS:We used data from 513 subjects at the 3-year follow-up from the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort. The predicted outcomes were non-achievement of remission, severe disease course, and functional disability. The Nordic models were evaluated exactly as published and after fine-tuning the logistic regression coefficients using multiple data splits of the Canadian cohort. Missing data was handled wit</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-26T06:30:56.109Z</modification><creation>2020-05-22T08:11:13Z</creation></dates><accession>S-EPMC6964007</accession><cross_references><pubmed>31941530</pubmed><doi>10.1186/s13075-019-2091-8</doi></cross_references></HashMap>